LIR-containing proteins in Rattus norvegicus>> EXPORT DATA
S.No. | Uniprot ID | Start | End | LIR Sequence | PSSM Score ▲ ▼ | Similar LIR Motifs | Molecular Function | Biological Process | Cellular Component |
2001 | Q5MPA9 | 401 | 406 | ESFTLL | 11 | cytoskeleton (GO:0005856) |
|||
2002 | Q5MPA9-2 | 401 | 406 | ESFTLL | 11 | ||||
2003 | Q5MPA9-3 | 385 | 390 | ESFTLL | 11 | ||||
2004 | Q5PPG6 | 87 | 92 | KEFQAL | 11 | nucleus (GO:0005634) |
|||
2005 | Q5PQK4 | 459 | 464 | SSFEPL | 12 | nucleus (GO:0005634) |
|||
2006 | Q5PQK4 | 691 | 696 | KSFVPV | 10 | nucleus (GO:0005634) |
|||
2007 | Q5PQM6 | 67 | 72 | SVWTPL | 14 | nucleus (GO:0005634) |
|||
2008 | Q5PQT2 | 939 | 944 | AGFDTL | 12 | membrane (GO:0016020); nucleus (GO:0005634) |
|||
2009 | Q5PQT4 | 325 | 330 | EEFQIV | 12 | nucleic acid binding (GO:0003676) |
nucleus (GO:0005634) |
||
2010 | Q5QD51 | 351 | 356 | ADYEKV | 15 | cytoskeleton (GO:0005856) |
|||
2011 | Q5QD51 | 532 | 537 | GEYQHI | 12 | cytoskeleton (GO:0005856) |
|||
2012 | Q5QD51 | 785 | 790 | ESWVSI | 19 | cytoskeleton (GO:0005856) |
|||
2013 | Q5QD51 | 833 | 838 | SEYDAV | 13 | cytoskeleton (GO:0005856) |
|||
2014 | Q5QD51-2 | 271 | 276 | ADYEKV | 15 | ||||
2015 | Q5QD51-2 | 452 | 457 | GEYQHI | 12 | ||||
2016 | Q5QD51-2 | 705 | 710 | ESWVSI | 19 | ||||
2017 | Q5QD51-2 | 753 | 758 | SEYDAV | 13 | ||||
2018 | Q5QD51-3 | 246 | 251 | ADYEKV | 15 | ||||
2019 | Q5QD51-3 | 427 | 432 | GEYQHI | 12 | ||||
2020 | Q5QD51-3 | 680 | 685 | ESWVSI | 19 | ||||
2021 | Q5QD51-3 | 728 | 733 | SEYDAV | 13 | ||||
2022 | Q5RJK3 | 33 | 38 | ESFLLL | 11 | ||||
2023 | Q5RJN9 | 143 | 148 | LSYEKV | 10 | ||||
2024 | Q5RJT2 | 630 | 635 | DGFEVV | 14 | nucleolus (GO:0005730) |
|||
2025 | Q5RKG9 | 142 | 147 | AEFEDL | 12 | nucleotide binding (GO:0000166) |
|||
2026 | Q5RKI6 | 66 | 71 | GDFLIV | 14 | nucleus (GO:0005634) |
|||
2027 | Q5RKJ4 | 53 | 58 | DGFLSL | 13 | CBL_HUMAN(800-805) FGWLSL(4) | |||
2028 | Q5U1Y3 | 12 | 17 | SVFITL | 8 | intracellular membrane-bounded organelle (GO:0043231) |
|||
2029 | Q5U208 | 193 | 198 | RGYVIL | 14 | cell cycle (GO:0007049) |
|||
2030 | Q5U2N3 | 231 | 236 | DEWIEL | 22 | T53I1_HUMAN(29-34) DEWILV(4); TBCD5_HUMAN(57-62) KEWEEL(4) |
protein transport (GO:0015031) |
midbody (GO:0030496) |
|
2031 | Q5U2N3 | 570 | 575 | LGFDAL | 10 | protein transport (GO:0015031) |
midbody (GO:0030496) |
||
2032 | Q5U2P6 | 119 | 124 | PGFLPL | 10 | ||||
2033 | Q5U2R3 | 451 | 456 | GSYTVV | 11 | cytoskeleton (GO:0005856) |
|||
2034 | Q5U2U3 | 310 | 315 | RDYQLL | 16 | ||||
2035 | Q5U2U8 | 93 | 98 | PGYIPI | 11 | neuron projection (GO:0043005) |
|||
2036 | Q5U2U8 | 206 | 211 | RGYIPI | 12 | neuron projection (GO:0043005) |
|||
2037 | Q5U2V1 | 490 | 495 | AGYLFV | 11 | protein folding (GO:0006457) |
membrane (GO:0016020) |
||
2038 | Q5U2X6 | 40 | 45 | AEFEDV | 11 | endoplasmic reticulum (GO:0005783) |
|||
2039 | Q5U312 | 785 | 790 | ASYEKL | 12 | FUND1_HUMAN(16-21) DSYEVL(4) | cytoskeleton (GO:0005856); nucleus (GO:0005634) |
||
2040 | Q5U312-2 | 756 | 761 | ASYEKL | 12 | FUND1_HUMAN(16-21) DSYEVL(4) | |||
2041 | Q5U328 | 513 | 518 | ATFIKV | 9 | nucleic acid binding (GO:0003676); nucleotide binding (GO:0000166) |
|||
2042 | Q5U342 | 327 | 332 | DEYDDI | 16 | ||||
2043 | Q5U4E6 | 566 | 571 | SEYLKL | 13 | ||||
2044 | Q5UEM7 | 19 | 24 | GSFLEL | 11 | nucleus (GO:0005634) |
|||
2045 | Q5UEM7-2 | 19 | 24 | GSFLEL | 11 | ||||
2046 | Q5XHX2 | 604 | 609 | GGYLAL | 11 | ||||
2047 | Q5XHX2 | 676 | 681 | KSFTVL | 11 | ||||
2048 | Q5XI01 | 387 | 392 | KEYLAL | 12 | nucleotide binding (GO:0000166) |
RNA processing (GO:0006396) |
ribonucleoprotein complex (GO:0030529) |
|
2049 | Q5XI13 | 67 | 72 | LSFDIV | 10 | nucleolus (GO:0005730) |
|||
2050 | Q5XI29 | 106 | 111 | GVYDVV | 8 | nucleotide binding (GO:0000166) |
mRNA cleavage factor complex (GO:0005849); nucleus (GO:0005634) |